Neil Desai
CIK 1878692 · EXECUTIVE CHAIRMAN · last filed 2026-06-15
Neil Desai is an EXECUTIVE CHAIRMAN who has filed 34 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for WHWK, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. 6 Form 144 notices of planned sales are also on file; the latest, for WHWK on Sep 3, 2024, lists the filer as an officer. 22 sales listed on those notices, worth $1.5M in all, have no matching Form 4.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AADI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
17383 SUNSET BLVD., SUITE A250
PACIFIC PALISADES, CA 90272
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | Director | — | $3.13 | — | $0 | 2 | 2026-06-15 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | EXECUTIVE CHAIRMAN | 1,171,543 | $2.05 | $2.40M | -$3.01M | 26 | 2024-09-05 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| AADI | Neil Prafulla Desai See footnote |
1,171,543 | 100.0% | 2024-09-05 |
| Total | 1,171,543 |
10b5-1 Trading Plans
1 plan| Company | Adopted | Sales Can Start | Ends | Plan Allows | Sold So Far | Status | Link |
|---|---|---|---|---|---|---|---|
| AADI director and our former Executive Chairman |
— | — | Ended Sep 28, 2024 | — | — | Ended early | 10-Q |
Recent Filings
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2025-06-17 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2024-09-05 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −40,000 | -$68.3K | EDGAR |
| 2024-09-03 | WHWK | Notice (144) Officer · Planned Sep 3, 2024 · 10b5-1 plan No sale on file |
−120,000 | -$214.4K | EDGAR |
| 2024-08-05 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −40,000 | -$57.4K | EDGAR |
| 2024-07-02 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −40,000 | -$57.2K | EDGAR |
| 2024-06-05 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −40,000 | -$71.5K | EDGAR |
| 2024-06-03 | WHWK | Notice (144) Officer · Planned Jun 3, 2024 · 10b5-1 plan Sold: listed on the Sep 3, 2024 notice |
−120,000 | -$220.0K | EDGAR |
| 2024-05-01 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −40,000 | -$77.2K | EDGAR |
| 2024-04-03 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Sell (S) | −40,000 | -$90.6K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
22 sales · $1.55M| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2024-08-05 | WHWK | 5,652 | $7.6K | $1.34 | 2024-09-03 |
| 2024-08-02 | WHWK | 18,933 | $26.7K | $1.41 | 2024-09-03 |
| 2024-08-01 | WHWK | 15,415 | $23.1K | $1.50 | 2024-09-03 |
| 2024-07-02 | WHWK | 8,652 | $11.6K | $1.34 | 2024-09-03 |
| 2024-07-01 | WHWK | 31,348 | $45.6K | $1.45 | 2024-09-03 |
| 2024-05-01 | WHWK | 40,000 | $77.2K | $1.93 | 2024-06-03 |
| 2024-04-02 | WHWK | 22,228 | $49.5K | $2.23 | 2024-06-03 |
| 2024-04-01 | WHWK | 17,772 | $41.1K | $2.31 | 2024-06-03 |
| 2023-12-04 | WHWK | 10,876 | $56.0K | $5.15 | 2024-03-01 |
| 2023-11-02 | WHWK | 31,662 | $141.1K | $4.46 | 2023-12-01 |
| 2023-11-01 | WHWK | 10,338 | $44.6K | $4.32 | 2023-12-01 |
| 2023-10-03 | WHWK | 16,431 | $67.3K | $4.10 | 2023-12-01 |
| 2023-10-02 | WHWK | 25,569 | $111.7K | $4.37 | 2023-12-01 |
| 2023-09-06 | WHWK | 7,111 | $37.6K | $5.29 | 2023-12-01 |
| 2023-09-05 | WHWK | 21,000 | $118.3K | $5.63 | 2023-12-01 |
| 2023-08-02 | WHWK | 19,290 | $100.2K | $5.20 | 2023-09-01 |
| 2023-08-01 | WHWK | 22,710 | $118.5K | $5.22 | 2023-09-01 |
| 2023-07-06 | WHWK | 15,829 | $99.3K | $6.27 | 2023-09-01 |
| 2023-07-05 | WHWK | 16,171 | $105.8K | $6.54 | 2023-09-01 |
| 2023-07-03 | WHWK | 10,000 | $66.4K | $6.64 | 2023-09-01 |
| 2023-06-06 | WHWK | 7,260 | $59.5K | $8.19 | 2023-07-03 |
| 2023-06-05 | WHWK | 17,315 | $140.4K | $8.11 | 2023-09-01 |